Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pcoopman
Group name EquipePC
Item Type Journal Article
Title SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro
Creator Tümmler et al.
Author Conny Tümmler
Author Gianina Dumitriu
Author Malin Wickström
Author Peter Coopman
Author Andrey Valkov
Author Per Kogner
Author John Inge Johnsen
Author Ugo Moens
Author Baldur Sveinbjörnsson
Abstract Neuroblastoma is a malignancy arising from the developing sympathetic nervous system and the most common and deadly cancer of infancy. New therapies are needed to improve the prognosis for high-risk patients and to reduce toxicity and late effects. Spleen tyrosine kinase (SYK) has previously been identified as a promising drug target in various inflammatory diseases and cancers but has so far not been extensively studied as a potential therapeutic target in neuroblastoma. In this study, we observed elevated SYK gene expression in neuroblastoma compared to neural crest and benign neurofibroma. While SYK protein was detected in the majority of examined neuroblastoma tissues it was less frequently observed in neuroblastoma cell lines. Depletion of SYK by siRNA and the use of small molecule SYK inhibitors significantly reduced the cell viability of neuroblastoma cell lines expressing SYK protein. Moreover, SYK inhibition decreased ERK1/2 and Akt phosphorylation. The SYK inhibitor BAY 613606 enhanced the effect of different chemotherapeutic drugs. Transient expression of a constitutive active SYK variant increased the viability of neuroblastoma cells independent of endogenous SYK levels. Collectively, our findings suggest that targeting SYK in combination with conventional chemotherapy should be further evaluated as a treatment option in neuroblastoma.
Publication Cancers
Volume 11
Issue 2
Date Feb 10, 2019
Journal Abbr Cancers (Basel)
Language eng
DOI 10.3390/cancers11020202
ISSN 2072-6694
Library Catalog PubMed
Extra PMID: 30744170
Tags combination therapy, neuroblastoma, original, pediatric cancer, tyrosine kinase
Date Added 2019/02/15 - 12:52:52
Date Modified 2019/09/13 - 11:15:31
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés